SCHEMBL12377414

SCHEMBL12377414

C=C(C)c1ccc2c(-c3cccc4c3oc3ccccc34)c3cc(C(=C)C)ccc3c(-c3ccc4ccc5cccc6ccc3c4c56)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
AVPR1A P37288 1/20 0.32
ERBB2 P04626 1/20 0.32
CYP1A2 P05177 1/20 0.32
FYN P06241 1/20 0.32
MAOA P21397 1/20 0.32
ACHE P22303 1/20 0.32
AHR P35869 1/20 0.32
GGPS1 O95749 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
CASP3 P42574 1/20 0.32
GFER P55789 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
IDO1 P14902 2/20 0.31
CDC25A P30304 2/20 0.31
CDC25C P30307 2/20 0.31
ARSA P15289 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12229297 0.93 ALOX5 (0.36) ALOX5GGPS1
SCHEMBL13860947 0.89 ALOX5 (0.47) ALOX5AVPR1AAHRGGPS1NPC1
SCHEMBL12377417 0.86 ALOX5 (0.41) ALOX5AVPR1AAHRGGPS1NPC1
SCHEMBL12377416 0.85 ALOX5 (0.43) ALOX5AVPR1ACYP1A2GGPS1NPC1
SCHEMBL124811 0.85 ALOX5 (0.47) ALOX5ERBB2CYP1A2FYNMAOA
SCHEMBL2253334 0.81 ALOX5 (0.40) ALOX5ERBB2CYP1A2FYNMAOA
SCHEMBL12229902 0.81 ALOX5 (0.40) ALOX5AVPR1AAHRGGPS1NPC1
SCHEMBL22854842 0.81 ALOX5 (0.45) ALOX5ERBB2CYP1A2FYNMAOA
SCHEMBL22854788 0.80 ALOX5 (0.47) ALOX5ERBB2CYP1A2FYNMAOA
SCHEMBL25969525 0.79 ALOX5 (0.46) ALOX5ERBB2CYP1A2FYNMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989644-B2 Electroluminescent device BASF SE (DE) 2011-08-02 US disclosed
US-20090131673-A1 Electroluminescent Device UDC IRELAND LIMITED (IE) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131673-A1 Electroluminescent Device DDT, CD99, EED ALOX5 741/4885AVPR1A 4453/4885ERBB2 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.